MTNB - Matinas BioPharma Holdings, Inc.
0.601
0.025 4.160%
Share volume: 23,737
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.58
0.03
0.04%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-10-2025 | |
| Cash flow financing | -67.000 K | 1.647 M | 1.622 M | 64.000 K | |
| Other financing cash flows | -2.000 K | -1.000 K | -1.000 K | 64.000 K | |
| Cash flow | 6.079 M | -360.000 K | 0.000 | -1.090 M | |
| Net income | -4.275 M | -1.656 M | -5.245 M | -1.532 M | |
| Depreciation | 91.000 K | 18.000 K | 12.000 K | -1.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 9.646 M | 0.000 | 0.000 | 320.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 6.079 M | -360.000 K | -399.000 K | -1.090 M |